| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1From the Molecular Endocrinology and Oncology Research Center, Laval University Hospital (CHUL) Research Center, Québec City, Québec, Canada; and the 3Cellular Pharmacology Laboratories, Department of Ophthalmology, School of Medicine, University of California, San Francisco, California.
PURPOSE. To investigate mechanism(s) by which mutations in the olfactomedin domain of myocilin (MYOC), also known as the trabecular meshwork–induced glucocorticoid response (TIGR) gene, cause autosomal dominant open-angle glaucoma, the structure and properties of wild-type (WT) MYOC protein were examined, when expressed alone or simultaneously with the Q368X or K423E disease-associated polypeptides.
METHODS. Myocilin was analyzed in human aqueous humor and human trabecular meshwork (HTM) tissues. COS-7 and immortalized human trabecular meshwork (iHTM) cell lines were transfected with expression vectors encoding WT MYOC, mutated, and/or epitope-tagged cDNAs. MYOC proteins were characterized by double-epitope tagging procedures and/or Western blot analysis.
RESULTS. MYOC polypeptides formed highly similar oligomers in aqueous humor, HTM tissues, transfected COS-7, and iHTM cell lines. These complexes ranged in size from 116 kDa to more than 200 kDa. The smallest complex, approximately 116 kDa, resulted from dimerization between two MYOC monomers. Expression of a 150-kDa complex was strongest in aqueous humor. Cotransfections of the WT construct with either the Q368X or K423E cDNA produced MYOCWT/MYOCmutant heterodimers and higher molecular weight hetero-oligomeric complexes. WT homo-oligomeric complexes were secreted in the extracellular media of both cell lines whereas the Q368X and K423E mutant/mutant homomultimers and heteromeric WT/mutant oligomers remained sequestered intracellularly.
CONCLUSIONS. Formation of heteromeric WT/mutant complexes may provide a critical mechanism by which mutant myocilin polypeptides produce autosomal dominant open-angle glaucoma. The intracellular sequestration of abnormal WT/mutant complexes could lead to the malfunction of MYOC-expressing cells and to POAG potentially involving a dominant negative effect.
This article has been cited by other articles:
|
|
 |
|
  J. Kuchtey, M. E. Kallberg, K. N. Gelatt, T. Rinkoski, A. M. Komaromy, and R. W. Kuchtey Angiopoietin-like 7 Secretion Is Induced by Glaucoma Stimuli and Its Concentration Is Elevated in Glaucomatous Aqueous Humor Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3438 - 3448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhou, O. Grinchuk, and S. I. Tomarev Transgenic Mice Expressing the Tyr437His Mutant of Human Myocilin Protein Develop Glaucoma Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 1932 - 1939. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. W. Rozsa, K. Scott, H. Pawar, S. Moroi, and J. E. Richards Effects of Timolol on MYOC, OPTN, and WDR36 RNA Levels Arch Ophthalmol, January 1, 2008; 126(1): 86 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. H.-F. Yam, K. Gaplovska-Kysela, C. Zuber, and J. Roth Sodium 4-Phenylbutyrate Acts as a Chemical Chaperone on Misfolded Myocilin to Rescue Cells from Endoplasmic Reticulum Stress and Apoptosis Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1683 - 1690. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Shepard, N. Jacobson, J. C. Millar, I.-H. Pang, H. T. Steely, C. C. Searby, V. C. Sheffield, E. M. Stone, and A. F. Clark Glaucoma-causing myocilin mutants require the Peroxisomal targeting signal-1 receptor (PTS1R) to elevate intraocular pressure Hum. Mol. Genet., March 15, 2007; 16(6): 609 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Wiggs Genetic Etiologies of Glaucoma Arch Ophthalmol, January 1, 2007; 125(1): 30 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. H.-F. Yam, K. Gaplovska-Kysela, C. Zuber, and J. Roth Aggregated Myocilin Induces Russell Bodies and Causes Apoptosis: Implications for the Pathogenesis of Myocilin-Caused Primary Open-Angle Glaucoma Am. J. Pathol., January 1, 2007; 170(1): 100 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Gould, M. Reedy, L. A. Wilson, R. S. Smith, R. L. Johnson, and S. W. M. John Mutant Myocilin Nonsecretion In Vivo Is Not Sufficient To Cause Glaucoma Mol. Cell. Biol., November 15, 2006; 26(22): 8427 - 8436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Malyukova, H.-S. Lee, R. N. Fariss, and S. I. Tomarev Mutated Mouse and Human Myocilins Have Similar Properties and Do Not Block General Secretory Pathway Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 206 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Fan, D. Y. L. Leung, D. Y. Wang, S. Gobeil, V. Raymond, P. O. S. Tam, D. S. C. Lam, and C. P. Pang Novel Myocilin Mutation in a Chinese Family With Juvenile-Onset Open-Angle Glaucoma Arch Ophthalmol, January 1, 2006; 124(1): 102 - 106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Grinchuk, Z. Kozmik, X. Wu, and S. Tomarev The Optimedin Gene Is a Downstream Target of Pax6 J. Biol. Chem., October 21, 2005; 280(42): 35228 - 35237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Thakkinstian, M. McEvoy, C. Minelli, P. Gibson, B. Hancox, D. Duffy, J. Thompson, I. Hall, J. Kaufman, T.-f. Leung, et al. Systematic Review and Meta-Analysis of the Association between {beta}2-Adrenoceptor Polymorphisms and Asthma: A HuGE Review Am. J. Epidemiol., August 1, 2005; 162(3): 201 - 211. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
